Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Stacey Murray

Nurse Practitioner Foxboro, MA Nurse Practitioner

NPI 1467633743 CMS profile 10628823

9 Payson Rd Ste 100, Foxboro, MA 02035

Open in the dashboard

General payments

$12,591

159 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Stacey Murray of Foxboro, MA is reported in the CMS Open Payments database as having received $12,591 across 159 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Nurse Practitioner profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $16 1
2022 General $716 28
2021 General $11,858 130

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Stacey Murray
  • Nurse Practitioner median
  • Middle half of Nurse Practitioner
  • National median

In program year 2025, general payments to Stacey Murray were reported at $16. Among 41,044 Nurse Practitioner profiles paid that year, the median was $174 and the middle half received between $55 and $557.

Show as a table
Year Stacey Murray Nurse Practitioner median Middle half National median
2019 $0 $50 $22–$97 $163
2020 $0 $40 $16–$108 $114
2021 $11,858 $135 $40–$426 $132
2022 $716 $152 $48–$470 $149
2023 $0 $166 $54–$529 $160
2024 $0 $173 $55–$556 $164
2025 $16 $174 $55–$557 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Biogen, Inc. $7,875 29 payments
  2. Celgene Corporation $1,348 10 payments
  3. E.R. Squibb & Sons, L.L.C. $1,064 2 payments
  4. EMD Serono, Inc. $376 10 payments
  5. Lundbeck LLC $198 9 payments
  6. Biohaven Pharmaceuticals, Inc. $193 18 payments
  7. Novartis Pharmaceuticals Corporation $174 14 payments
  8. Sunovion Pharmaceuticals Inc. $123 6 payments
  9. Horizon Therapeutics plc $121 2 payments
  10. AbbVie, Inc. $99 5 payments
  11. Other $1,019 54 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $8,354 12 payments
  2. Food and Beverage $2,868 143 payments
  3. Consulting Fee $1,206 1 payment
  4. Education $163 3 payments
Products named General payments · program years 2021–2025
  1. TYSABRI $6,762 15 payments
  2. ZEPOSIA $2,412 12 payments
  3. VUMERITY $2,230 17 payments
  4. AVONEX $1,287 5 payments
  5. PLEGRIDY $1,283 5 payments
  6. TECFIDERA $1,206 1 payment
  7. VYEPTI $198 9 payments
  8. NURTEC ODT $193 18 payments
  9. AUBAGIO $147 6 payments
  10. KESIMPTA $139 9 payments
  11. Other $1,370 76 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

159 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record